Navigation Links
GBM -Ab EIA Auto-Immune Markers 013-GBM-48 Glomerular Basement Membrane

ProductsGBM -Ab EIA Auto-Immune Markers 013-GBM-48 Glomerular Basement Membrane
Company ALPCO Diagnostics
Item GBM -Ab EIA Auto-Immune Markers 013-GBM-48 Glomerular Basement Membrane
Features 
Description This Immunoscan Anti-GBM was developed to detect the presence of antibodies against the glomerular basement membrane. The information is clinically useful in diagnosing Goodpastures syndrome, where anti-collagen (IV) - a3 chain antibody formation along with glomerulonephritis and pulmonary hemorrhage are primary diagnostic parameters. Since there are several other conditions presenting with similar symptoms, developed independently from anti-glomerular basement membrane (GBM) antibodies, this test can help to differentiate between these autoimmune renal disorders. The antigen used in the test is the M2 subunit purified from the noncollagenous (NC1) domain of type IV collagen. This antigen is fully described in the review article Biology of Disease Goodpasture Syndrome: Molecular Architecture and Function of Basement Membrane Antigen (1). Recent studies have shown that all Goodpasture patients have antibodies directed against M2 and some patients have additional antibodies against other basement membrane constituents and/or other collagen IV domains. The use of this purified antigen does not give false positive results for patient specimens containing other autoantibodies to the GBM, in contrast to crude collagenase digests of the total GBM (2). Glomerulonephritis is a major cause of irreversible renal failure. Many forms of glomerulonephritis are caused by immunological mechanisms, whereby a person forms antibodies against his own tissue components (auto-immunity) (3). Dixon and coworkers (4, 5) showed that in one particular type of glomerulonephritis, originally described by Ernest Goodpasture in 1919 (6) and subsequently referred to as Goodpastures syndrome (7), the disease was caused by an antibody response against antigens present in the glomerular basement membrane (GBM). Thus the disease is sometimes referred to as anti-GBM mediated glomerulonephritis. While Goodpastures syndrome is a relatively rare condition, the disease is rapidly progressive and, unless treated, has a case-fatality rate of 75-90% (8). Immediate and correct treatment is necessary before kidney (and often lung) damage has progressed too far. In clinical practice the diagnosis and recognition of the disease is frequently delayed since it is unexpected. Clinical signs such as hemoptysis, precipitate anemia, pulmonary opacities at x-ray and/or oliguria are in a sense unspecific and common to a variety of disorders. Mild prodromal lung or kidney symptoms are often overlooked or masked by a precipitating infection. The Immunoscan Anti-GBM offered is based on ELISA methodology (15, 16). The test utilizes wells coated with purified GBM antigen. Diluted patient serum is applied to the well and incubated. If specific anti-GBM antibodies are present they will bind to the antigen. Unbound material is washed away and any bound antibody is detected by adding enzyme-labeled anti-human IgG, followed by a second washing step and incubation with substrate. A well containing anti-GBM antibody will develop a color, which can be quantified.
Info ALPCO DiagnosticsCall ALPCO Diagnostics to buy products (US and Canada only; other locations use number below) USACanada1-866-466-7731

Customer Service: (800) 592-5726
Web site: http://www.alpco.com

Related medicine products :

1. CIC (C1-q) EIA Auto-Immune Markers 001-EK-CIC Circulating Immune Complexes
2. GBM -Ab EIA Auto-Immune Markers 013-GBM-96 Glomerular Basement Membrane
3. Anti-PR3 EIA Auto-Immune Markers 013-PR3-48 Proteinase
4. Anti-MPO ANCA EIA Auto-Immune Markers 013-MPO-96 Myeloperoxidase
5. Anti-PR3 EIA Auto-Immune Markers 013-PR3-96 Proteinase
6. Anti-MPO ANCA EIA Auto-Immune Markers 013-MPO-48 Myeloperoxidase
7. ENA Screen EIA Auto-Immune Markers 012-MDKES1 Extractable Nuclear Antigens
8. Surgical Markers
9. TLS Surgical Markers
10. SQUEEZE-MARK Surgical Markers
11. Iso-Insulin EIA Diabetes and Obesity Markers 008-10-1128-01
This 10 L tip was designed for the Pipetman P-2 and P-10. Its MicroPoint design and 2 L reference mark make it ideal for low volume pipetting....
... tips. Each box contains 1000 tips (5 bags ... tips (4 bags of 50 tips). Also available ... per pack. Bulk Packs are sealed with a ... quick access to Gilsons Diamond Tips. Bulk Packs ...
1000 L, Bulk Recommended for 500 and 1000 L pipettes....
... designed to optimize the accuracy and precision ... products is widely recognized by customers throughout ... extended over the years and now covers ... tips including filter tips, certified pure tips, ...
Medicine Products:
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016   Bay Area Lyme ... Dean Center for Tick Borne Illness , ... Rehabilitation, MIT Hacking Medicine, University of California, Berkeley, ... announced the five finalists of Lyme Innovation ... More than 100 scientists, clinicians, researchers, entrepreneurs, and ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June 24, 2016 ... mobile pulmonary function testing company, is now able to perform sophisticated ... by ndd Medical Technologies , Inc. Patients ... hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients ... get any needed testing done in the comfort of her own ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: